Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CGON

CG Oncology (CGON)

CG Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CGON
DateTimeSourceHeadlineSymbolCompany
01/10/20253:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGONCG Oncology Inc
12/17/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGONCG Oncology Inc
12/16/20243:05PMGlobeNewswire Inc.CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CGONCG Oncology Inc
12/13/20243:07PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:CGONCG Oncology Inc
12/12/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CGONCG Oncology Inc
12/12/20247:19PMGlobeNewswire Inc.CG Oncology Announces Pricing of Public OfferingNASDAQ:CGONCG Oncology Inc
12/11/20243:09PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:CGONCG Oncology Inc
12/11/20245:17AMGlobeNewswire Inc.CG Oncology Announces Proposed Public OfferingNASDAQ:CGONCG Oncology Inc
12/06/20247:00AMGlobeNewswire Inc.SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship AwardNASDAQ:CGONCG Oncology Inc
12/05/20246:52AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGONCG Oncology Inc
12/05/20246:00AMGlobeNewswire Inc.Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder CancerNASDAQ:CGONCG Oncology Inc
12/02/20247:00AMGlobeNewswire Inc.CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Thursday, December 5, 2024NASDAQ:CGONCG Oncology Inc
11/20/20247:00AMGlobeNewswire Inc.CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual MeetingNASDAQ:CGONCG Oncology Inc
11/12/20247:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGONCG Oncology Inc
11/12/20247:00AMGlobeNewswire Inc.CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:CGONCG Oncology Inc
11/11/20247:00AMGlobeNewswire Inc.CG Oncology Announces Nature Medicine Publication of Phase 1b Study Results Evaluating Cretostimogene Grenadenorepvec in Combination with Nivolumab in Muscle-Invasive Bladder CancerNASDAQ:CGONCG Oncology Inc
11/08/20241:17PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CGONCG Oncology Inc
10/07/20244:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGONCG Oncology Inc
10/07/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGONCG Oncology Inc
10/07/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGONCG Oncology Inc
10/07/20244:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGONCG Oncology Inc
10/07/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGONCG Oncology Inc
08/30/20246:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGONCG Oncology Inc
08/30/20247:00AMGlobeNewswire Inc.CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:CGONCG Oncology Inc
08/29/20247:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CGONCG Oncology Inc
08/29/20245:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CGONCG Oncology Inc
08/08/20247:23AMGlobeNewswire Inc.CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:CGONCG Oncology Inc
08/08/20245:19AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CGONCG Oncology Inc
08/08/20245:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGONCG Oncology Inc
06/18/20247:00AMGlobeNewswire Inc.CG Oncology Initiates Expanded Access Program for Cretostimogene GrenadenorepvecNASDAQ:CGONCG Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:CGON

Your Recent History

Delayed Upgrade Clock